|
"tzeng he"的相关文件
显示项目 1-4 / 4 (共1页)
1
每页显示[10|25|50]项目
| 國家衛生研究院 |
2021-07-07 |
The effectiveness and safety of immune checkpoint inhibitors in non-small cell lung cancer patients with stage III/IV: A multicenter study
|
Hsu, JC;Nguyen, PA;Chen, YT;Yang, SC;Lin, CC;Yang, YH;Lin, YC;Hsia, TC;Hsieh, HC;Wu, JS;Chang, CP;Feng, YH;Lin, PC;Hsu, PC;Tzeng, HE;Chien, SC;Chang, WC;Chang, CC;Yang, HC;Lee, CM;Lu, CY |
| 亞洲大學 |
201502 |
CCL5 promotes vascular endothelial growth factor expression and induces angiogenesis by down-regulating miR-199a in human chondrosarcoma cells
|
Liu, GT;Liu, GT;黃元勵;HUANG, YUAN-LI;Tzeng, HE;Tzeng, HE;Tsai, CH;Tsai, CH;Wang, SW;Wang, SW;Tang, CH;Tang, CH |
| 亞洲大學 |
2015-02 |
CCL5 promotes vascular endothelial growth factor expression and induces angiogenesis by down-regulating miR-199a in human chondrosarcoma cells
|
Liu, GT;Liu, GT;黃元勵;HUANG, YUAN-LI;Tzeng, HE;Tzeng, HE;Tsai, CH;Tsai, CH;Wang, SW;Wang, SW;Tang, CH;Tang, CH |
| 臺北醫學大學 |
2015 |
The pan-PI3K inhibitor GDC-0941 activates canonical WNT signaling to confer resistance in TNBC cells: resistance reversal with WNT inhibitor
|
Tzeng, HE;Yang, L;Chen, K;Wang, Y;Liu, YR;Pan, SL;Gaur, S;Hu, S;Yen, Y. |
显示项目 1-4 / 4 (共1页)
1
每页显示[10|25|50]项目
|
